BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 19274031)

  • 1. Role of stem and progenitor cells in postmyocardial infarction patients.
    Liu X; Dauwe D; Patel A; Janssens S
    Minerva Cardioangiol; 2009 Apr; 57(2):219-31. PubMed ID: 19274031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Stem cells after myocardial infarction].
    Schächinger V; Dimmeler S; Zeiher AM
    Herz; 2006 Apr; 31(2):127-36; quiz 142-3. PubMed ID: 16738836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized controlled trials on the therapeutic effects of adult progenitor cells for myocardial infarction: meta-analysis.
    Jiang M; He B; Zhang Q; Ge H; Zang MH; Han ZH; Liu JP; Li JH; Zhang Q; Li HB; Jin Y; He Q; Gong XR; Yin XY
    Expert Opin Biol Ther; 2010 May; 10(5):667-80. PubMed ID: 20384520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human bone marrow-derived adult stem cells for post-myocardial infarction cardiac repair: current status and future directions.
    Wei HM; Wong P; Hsu LF; Shim W
    Singapore Med J; 2009 Oct; 50(10):935-42. PubMed ID: 19907881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stem cell therapy in acute myocardial infarction.
    Janssens S
    Acta Clin Belg; 2007; 62(5):342-7. PubMed ID: 18229469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human cardiomyocyte progenitor cell transplantation preserves long-term function of the infarcted mouse myocardium.
    Smits AM; van Laake LW; den Ouden K; Schreurs C; Szuhai K; van Echteld CJ; Mummery CL; Doevendans PA; Goumans MJ
    Cardiovasc Res; 2009 Aug; 83(3):527-35. PubMed ID: 19429921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new direction for cardiac regeneration therapy: application of synergistically acting epicardium-derived cells and cardiomyocyte progenitor cells.
    Winter EM; van Oorschot AA; Hogers B; van der Graaf LM; Doevendans PA; Poelmann RE; Atsma DE; Gittenberger-de Groot AC; Goumans MJ
    Circ Heart Fail; 2009 Nov; 2(6):643-53. PubMed ID: 19919990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cardiac cell therapy: the puzzle is waiting to be solved].
    Canepa M; Coviello D; Chiarella F
    G Ital Cardiol (Rome); 2006 Apr; 7(4):252-65. PubMed ID: 16700408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell therapy for heart failure--muscle, bone marrow, blood, and cardiac-derived stem cells.
    Ott HC; Davis BH; Taylor DA
    Semin Thorac Cardiovasc Surg; 2005; 17(4):348-60. PubMed ID: 16428043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stem cell sources for cardiac regeneration.
    Roccio M; Goumans MJ; Sluijter JP; Doevendans PA
    Panminerva Med; 2008 Mar; 50(1):19-30. PubMed ID: 18427385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone marrow cell transfer in acute myocardial infarction.
    Janssens S; Theunissen K; Boogaerts M; Van de Werf F
    Nat Clin Pract Cardiovasc Med; 2006 Mar; 3 Suppl 1():S69-72. PubMed ID: 16501635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adipose tissue: a new source for cardiovascular repair.
    Madonna R; De Caterina R
    J Cardiovasc Med (Hagerstown); 2010 Feb; 11(2):71-80. PubMed ID: 19996982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cell therapy for acute myocardial infarction].
    Lemarchand P
    Transfus Clin Biol; 2009 May; 16(2):146-7. PubMed ID: 19443255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progenitor cell therapy for heart disease.
    Gonzales C; Pedrazzini T
    Exp Cell Res; 2009 Nov; 315(18):3077-85. PubMed ID: 19747911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiomyocyte-specific overexpression of human stem cell factor improves cardiac function and survival after myocardial infarction in mice.
    Xiang FL; Lu X; Hammoud L; Zhu P; Chidiac P; Robbins J; Feng Q
    Circulation; 2009 Sep; 120(12):1065-74, 9 p following 1074. PubMed ID: 19738140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Stem cell therapy in cardiovascular diseases].
    Vértesaljai M; Piróth Z; Fontos G; Andréka G; Font G; Szánthó G; Réti M; Masszi T; Andréka P
    Orv Hetil; 2005 Nov; 146(47):2383-8. PubMed ID: 16398150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transplanted human cord blood-derived unrestricted somatic stem cells improve left-ventricular function and prevent left-ventricular dilation and scar formation after acute myocardial infarction.
    Ghodsizad A; Niehaus M; Kögler G; Martin U; Wernet P; Bara C; Khaladj N; Loos A; Makoui M; Thiele J; Mengel M; Karck M; Klein HM; Haverich A; Ruhparwar A
    Heart; 2009 Jan; 95(1):27-35. PubMed ID: 18519547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone-marrow-derived progenitor cell therapy in need of proof of concept: design of the REPAIR-AMI trial.
    Schächinger V; Tonn T; Dimmeler S; Zeiher AM
    Nat Clin Pract Cardiovasc Med; 2006 Mar; 3 Suppl 1():S23-8. PubMed ID: 16501626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adult stem cells in the treatment of acute myocardial infarction.
    Sharif F; Bartunek J; Vanderheyden M
    Catheter Cardiovasc Interv; 2011 Jan; 77(1):72-83. PubMed ID: 20506335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stem cell therapy in cardiovascular disorders.
    Krause K; Schneider C; Kuck KH; Jaquet K
    Cardiovasc Ther; 2010 Oct; 28(5):e101-10. PubMed ID: 21050418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.